Compare HubSpot Inc (HUBS) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

HubSpot (HUBS) trades at $233.94, up 6.19% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $3.26, beating estimates of $3.02, continuing a trend of positive surprises. Revenue growth is robust, with 2025 revenue at $3.13 billion, and net income turning positive at $45.91 million. Analyst sentiment remains largely positive with a consensus price target of $243.65, though valuation multiples like a P/E of 82.51 are elevated. Recent news highlights AI strategy advancements and partnerships, including a deepened collaboration with OpenAI.

The outlook for HUBS is cautiously optimistic, driven by strong revenue growth, margin expansion potential, and strategic AI initiatives. Key risks include high valuation multiples, competitive pressures in the CRM space, and potential demand headwinds from economic conditions. Institutional ownership trends show significant interest, such as the California State Teachers Retirement System increasing its stake. The stock presents a growth opportunity but requires monitoring of execution risks and market sentiment shifts.

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.